A detailed history of Allworth Financial LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Allworth Financial LP holds 31,502 shares of NVO stock, worth $3.23 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31,502
Previous 30,440 3.49%
Holding current value
$3.23 Million
Previous $4.35 Million 13.69%
% of portfolio
0.02%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$119.07 - $145.42 $126,452 - $154,436
1,062 Added 3.49%
31,502 $3.75 Million
Q2 2024

Jul 23, 2024

BUY
$122.71 - $146.91 $159,891 - $191,423
1,303 Added 4.47%
30,440 $4.35 Million
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $1.33 Million - $1.77 Million
13,022 Added 80.81%
29,137 $3.74 Million
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $395,361 - $474,946
4,504 Added 38.79%
16,115 $1.67 Million
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $617,937 - $1.36 Million
6,795 Added 141.09%
11,611 $1.06 Million
Q2 2023

Jul 18, 2023

BUY
$155.98 - $172.65 $351,266 - $388,807
2,252 Added 87.83%
4,816 $779,000
Q1 2023

Apr 18, 2023

BUY
$132.34 - $159.14 $30,173 - $36,283
228 Added 9.76%
2,564 $408,000
Q4 2022

Jan 13, 2023

BUY
$102.55 - $135.33 $7,178 - $9,473
70 Added 3.09%
2,336 $0
Q3 2022

Oct 18, 2022

BUY
$95.28 - $116.93 $164,643 - $202,055
1,728 Added 321.19%
2,266 $226,000
Q2 2022

Jul 13, 2022

BUY
$103.24 - $121.81 $14,247 - $16,809
138 Added 34.5%
538 $60,000
Q2 2021

Aug 02, 2021

BUY
$67.66 - $84.76 $26,928 - $33,734
398 Added 19900.0%
400 $34,000
Q1 2020

Apr 17, 2020

BUY
$49.46 - $64.78 $98 - $129
2 New
2 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.